LabCompass

Publications

29

Citations

62

Est. group size

Recurring co-author estimate

Active years

6

Publishing since 2021

Research summary
AI-generated

Eyram Kpenu works in biochemistry and molecular biology, with recent research spanning cancer drug resistance and the biology of how cells respond to stress and DNA damage. One recent study focuses on inhibitors targeting a protein (Ref-1) involved in resistance to pancreatic cancer treatment, while another examines how plant chemical signals affect a bacterial pathogen. This suggests work that connects molecular signaling to both disease and plant-microbe interactions.

Cancer therapeutics and drug resistanceDNA repair mechanismsRedox biology and oxidative stressEndoplasmic reticulum stressPlant-microbe interactions

Publication activity has been growing markedly in recent years, rising from occasional papers before 2023 to several per year, with the highest counts reported in the most recent years.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 5.6/year recently
171819202021: 1 publication21222023: 3 publications232024: 3 publications242025: 7 publications252026: 15 publications1526
Publishes in
  • Figshare×14
  • Redox Biology×2
  • The FASEB Journal×2
  • Cancer Research×2
  • Frontiers in Medicine×1

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile